V W M van Hinsbergh
Overview
Explore the profile of V W M van Hinsbergh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
811
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Amado-Azevedo J, Reinhard N, van Bezu J, van Nieuw Amerongen G, van Hinsbergh V, Hordijk P
Vascul Pharmacol
. 2017 Nov;
101:38-47.
PMID: 29174013
Endothelial cells line the vasculature and act as gatekeepers that control the passage of plasma, macromolecules and cells from the circulation to the interstitial space. Dysfunction of the endothelial barrier...
2.
Amado-Azevedo J, Reinhard N, van Bezu J, de Menezes R, van Beusechem V, van Nieuw Amerongen G, et al.
Sci Rep
. 2017 Sep;
7(1):10132.
PMID: 28860633
Endothelial barrier function is carefully controlled to protect tissues from edema and damage inflicted by extravasated leukocytes. RhoGTPases, in conjunction with myriad regulatory proteins, exert both positive and negative effects...
3.
Boa B, Yudkin J, van Hinsbergh V, Bouskela E, Eringa E
Br J Pharmacol
. 2017 Feb;
174(20):3466-3481.
PMID: 28147449
Linked Articles: This article is part of a themed section on Molecular Mechanisms Regulating Perivascular Adipose Tissue - Potential Pharmacological Targets? To view the other articles in this section visit...
4.
Woudstra L, Krijnen P, Bogaards S, Meinster E, Emmens R, Kokhuis T, et al.
Stem Cell Res
. 2016 May;
17(1):6-15.
PMID: 27186654
Successful stem cell therapy after acute myocardial infarction (AMI) is hindered by lack of engraftment of sufficient stem cells at the site of injury. We designed a novel technique to...
5.
de Vries M, Seghers L, van Bergen J, Peters H, de Jong R, Hamming J, et al.
J Mol Cell Cardiol
. 2013 Sep;
64:51-8.
PMID: 24013026
Objective: NK cells are known to be involved in cardiovascular disease processes. One of these processes, vascular remodeling, may strongly differ between individuals and mouse strains such as the C57BL/6...
6.
Naaijkens B, Niessen H, Prins H, Krijnen P, Kokhuis T, de Jong N, et al.
Cell Tissue Res
. 2012 Mar;
348(1):119-30.
PMID: 22395775
Adipose-derived stromal cells (ASC) are promising candidates for cell therapy, for example to treat myocardial infarction. Commonly, fetal bovine serum (FBS) is used in ASC culturing. However, FBS has several...
7.
Rensing K, von der Thusen J, Weijers E, Houttuijn Bloemendaal F, van Lammeren G, Vink A, et al.
Atherosclerosis
. 2012 Feb;
222(1):208-15.
PMID: 22341865
Objective: Exogenous insulin use in patients with type 2 diabetes (DM2) has been associated with an increased risk of cardiovascular events. Through which mechanisms insulin may increase atherosclerotic plaque vulnerability...
8.
Weijers E, van Wijhe M, Joosten L, Horrevoets A, De Maat M, van Hinsbergh V, et al.
J Thromb Haemost
. 2010 Oct;
8(12):2800-9.
PMID: 20946180
Background: Fibrin is a temporary matrix that not only seals a wound, but also provides a temporary matrix structure for invading cells during wound healing. Two naturally occurring fibrinogen variants,...
9.
Mouchaers K, Schalij I, de Boer M, Postmus P, van Hinsbergh V, van Nieuw Amerongen G, et al.
Eur Respir J
. 2010 Mar;
36(4):800-7.
PMID: 20351034
Pulmonary arterial hypertension (PAH) still cannot be cured, warranting the search for novel treatments. Fasudil (a Rho kinase inhibitor) was compared with bosentan (an endothelin receptor blocker) and sildenafil (a...
10.
Vroling L, Lind J, de Haas R, Verheul H, van Hinsbergh V, Broxterman H, et al.
Br J Cancer
. 2009 Dec;
102(2):268-75.
PMID: 20010948
Background: Blood-based biomarkers may be particularly useful for patient selection and prediction of treatment response for angiogenesis inhibitors. Circulating endothelial cells (CECs) and haematopoietic progenitor cells (HPCs) might have a...